VSTM

#3167
Verastem, Inc. - Common Stock
4.2 8 USD
-0.23%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
4.24
4.33
Year Range
4.00
11.25
Daily Change
-0.23%
Monthly Change
-20.74%
6 month change
-58.81%
Year Change
-44.42%
Previous Close
4.2 9
Open
4.2 8
Low
4.2 4
High
4.3 3
Volume
164
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 376.1 M
  • Employee 102
  • Founded 2010
  • CEO Brian Stuglik
  • Website www.verastem.com
  • Headquarter Massachusetts, United States
  • FIGI BBG001J2LSK5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.56
Price to sales ratio
17.31

Verastem, Inc. - Common Stock

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

News